Gene · 5284
Papers2,361
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,361
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology. | Aging (Albany NY) | 2023 | 37285836 | PubTator, text mining | PubMed |
| Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration. | Sci Transl Med | 2023 | 37285404 | PubTator, text mining | PubMed |
| Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection. | PLoS Pathog | 2023 | 37262073 | PubTator, text mining | PubMed |
| Dysfunction of Foxp3+ Regulatory T Cells Induces Dysbiosis of Gut Microbiota via Aberrant Binding of Immunoglobulins to Microbes in the Intestinal Lumen. | Int J Mol Sci | 2023 | 37239894 | PubTator, text mining | PubMed |
| Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis. | EBioMedicine | 2023 | 37236058 | PubTator, text mining | PubMed |
| Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2. | MAbs | 2023 | 37229608 | PubTator, text mining | PubMed |
| A longitudinal study of fatty acid profiles, macronutrient levels, and plasmin activity in human milk. | Front Nutr | 2023 | 37229467 | PubTator, text mining | PubMed |
| Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks. | Nat Aging | 2023 | 37217661 | PubTator, text mining | PubMed |
| Polymeric immunoglobulin receptor (pIgR) in ray-finned fish (Actinopterygii). | Fish Shellfish Immunol | 2023 | 37211331 | PubTator, text mining | PubMed |
| Functional and Clinical Proteomic Exploration of Pancreatic Cancer. | Mol Cell Proteomics | 2023 | 37209817 | PubTator, text mining | PubMed |
| In-Depth Serum Proteomics Reveals the Trajectory of Hallmarks of Cancer in Hepatitis B Virus-Related Liver Diseases. | Mol Cell Proteomics | 2023 | 37209815 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective. | Mol Cell Proteomics | 2023 | 37209814 | PubTator, text mining | PubMed |
| Small extracellular vesicle-mediated metabolic reprogramming: from tumors to pre-metastatic niche formation. | Cell Commun Signal | 2023 | 37208722 | PubTator, text mining | PubMed |
| Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37190239 | PubTator, text mining | PubMed |
| Vitamin A deficiency and vitamin A supplementation affect innate and T cell immune responses to rotavirus A infection in a conventional sow model. | Front Immunol | 2023 | 37180172 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis. | Clin Proteomics | 2023 | 37179321 | PubTator, text mining | PubMed |
| PcTrim prevents early infection with white spot syndrome virus by inhibiting AP1-induced endocytosis. | Cell Commun Signal | 2023 | 37158899 | PubTator, text mining | PubMed |
| Plasmodium falciparum has evolved multiple mechanisms to hijack human immunoglobulin M. | Nat Commun | 2023 | 37156765 | PubTator, text mining | PubMed |
| A novel PD-1/PD-L1 pathway molecular typing-related signature for predicting prognosis and the tumor microenvironment in breast cancer. | Discov Oncol | 2023 | 37154982 | PubTator, text mining | PubMed |
| Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities. | Adv Sci (Weinh) | 2023 | 37150860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5284/papers?page=16